InvestorsHub Logo

Parkmart

01/16/17 11:16 AM

#43255 RE: mcsharkey #43254

The pharmas are going to have to look for profits somewhere. Getting rid of counterfeit drugs would be a step in the right direction.
Informed consumers have always known that the USA is their gravy train since we don't set drug prices like other countries.
Trump says he is going to do this.

speed_of_light

01/16/17 11:37 AM

#43256 RE: mcsharkey #43254

From most recent 10k:

"We believe that our 41 patents, 83 patent applications, 37 registered trademarks, and 8 trademark applications, and our trade secrets, copyrights and other intellectual property rights are important assets for us. Our patents will expire at various times between 2021 and 2032. "

It'd be interesting to know in what order they're rolling off and the implications for the business.

Also, have they obtained patents in other countries? My understanding is that patents are enforceable only in the countries in which they've been awarded.

Parkmart

01/16/17 12:14 PM

#43257 RE: mcsharkey #43254

Free patents online is a good starting point for research.
Patents expire every 20 years. Companies often improve these processes over time resulting in new patents. This usually avoids expiration.
I notice that several of the pending patents relate to DNA sequencing. These, I. Elieve, are designed to replace expiring ones.
Based on the awarded patents I have studied, I would expect APDN to take swift action against any violations.
I can understand the scientific staff at APDN being kept busy in this regard 25/7.
I don't understand what the financial and admin. Employees did last year.
I could handle a company this size in my spare time( financials, payroll, tax filings)
In fact I do do this for several companies larger than this.
And guess what? None of them gave me a single share of stock last year.
I am chomping at the bit to know why these huge option grants in December. Screw a full throated response. Just explain in plain English, how these were earned? What are they for?
We all do so want to know